Search
for
Sort by
Research 31–60 of 1000+
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Non-viral delivery of the CRISPR/Cas system: DNA<i>versus</i>RNA<i>versus</i>RNP
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Physical and mechanical cues affecting biomaterial-mediated plasmid DNA delivery: insights into non-viral delivery systems
- Associations between clinical data, vaccination status, antibody responses, and post-COVID-19 symptoms in Thais infected with SARS-CoV-2 Delta and Omicron variants: a 1-year follow-up study
- Vaccines, adjuvants and autoimmunity
- Gender Differences in Response to COVID-19 Infection and Vaccination
- Structural Elements of DNA and RNA Eukaryotic Expression Vectors for In Vitro and In Vivo Genome Editor Delivery
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- A case of extensive alopecia areata following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine with favorable outcome
- Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
- Vitamin D And Tmprss2: Intersecting Pathways In Post-Covid-19 Alopecia
- New Onset of Hair Loss Disorders During the Coronavirus Disease 2019 Pandemic: A Korean Nationwide Population-Based Study
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Gene therapy to enhance angiogenesis in chronic wounds
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- Cutaneous manifestations of systemic infection in children
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
- An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system
- Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review
- The Advances of Broad-Spectrum and Hot Anti-Coronavirus Drugs
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Diseases of Honeybee (Apis mellifera)
- Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection
- Cell Membrane-Camouflaged Nanoparticles Mediated Nucleic Acids Delivery
- Drug-associated gingival disorders: a retrospective pharmacovigilance assessment using disproportionality analysis